Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
291.37
-1.80 (-0.61%)
At close: Jun 26, 2026, 4:00 PM EDT
291.14
-0.23 (-0.08%)
After-hours: Jun 26, 2026, 6:19 PM EDT

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,500 employees as of December 31, 2025. The number of employees increased by 270 or 12.11% compared to the previous year.

Employees
2,500
Change (1Y)
270
Growth (1Y)
12.11%
Revenue / Employee
$1,714,769
Profits / Employee
$215,196
Market Cap
38.90B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20252,50027012.11%
Dec 31, 20242,2301306.19%
Dec 31, 20232,100984.90%
Dec 31, 20222,00233720.24%
Dec 31, 20211,66521214.59%
Dec 31, 20201,4531309.83%
Dec 31, 20191,32325824.23%
Dec 31, 20181,06531642.19%
Dec 31, 201774923545.72%
Dec 31, 201651414539.30%
Dec 31, 201536911344.14%
Dec 31, 20142569155.15%
Dec 31, 20131653627.91%
Dec 31, 20121291311.21%
Dec 31, 2011116-56-32.56%
Dec 31, 2010172-6-3.37%
Dec 31, 200917884.71%
Dec 31, 20081704131.78%
Dec 31, 200712975.74%
Dec 31, 20061222829.79%
Dec 31, 2005942332.39%
Dec 31, 2004711118.33%
Dec 31, 200360--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
Regeneron Pharmaceuticals 15,410
BeOne Medicines AG 12,000
BioNTech SE 7,807
Moderna 4,700
Incyte 2,844
argenx SE 1,863
Insmed 1,664
Ascendis Pharma 1,189
Employee Rankings

ALNY News

More News